Yu-Peng Wu,* Xiao-Dong Li,* Zhi-Bin Ke,* Shao-Hao Chen, Ping-Zhou Chen, Yong Wei, Jin-Bei Huang, Xiong-Lin Sun, Xue-Yi Xue, Qing-Shui Zheng, Ning Xu Department of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China *These authors contributed equally to this work Objective: To explore risk factors of infectious complications following transrectal ultrasound-guided prostate biopsy (TRUSPB).Methods: We retrospectively analyzed 1,203 patients with suspected prostate cancer who underwent TRUSPB at our center between December 2012 and December 2016. Demographics, clinical characteristics, and data regarding complications were collected, and then univariate and multivariate logistic regression analyses were used to i...
Introduction: There is still an ongoing debate whether a transrectal ultrasound (TRUS) approach for ...
We present a systematic review providing estimates of the overall and regional burden of infectious ...
Background:The ideal prophylaxis duration for transrectal ultrasonography-guided prostate biopsy is ...
Background: Transrectal ultrasound (TRUS) guided prostate needle biopsy is a commonly used diagnosti...
CONTEXT AND OBJECTIVE: Prostate biopsy is not a procedure without risk. There is concern about major...
Objectives: To determine the risk factors that affect the complication rates of transrectal ultrasou...
Objective: Prostate cancer is a common disease in men proportionally with age. For the diagnosis of ...
Objective: Infection and fever are a major issue of transrectal ultrasound (TRUS)-guided prostate bi...
PURPOSE: The aim of our study was to compare infectious complication rates between different prostat...
Objective: This study was carried out to compare infectious complications between patients with and ...
Background: Prostate biopsy is a standard tool for diagnosing prostate cancer, with more than 4 mill...
AbstractObjectiveInfection and fever are a major issue of transrectal ultrasound (TRUS)-guided prost...
OBJECTIVES: To investigate the complication rate within 30 days after transrectal ultrasound-guided ...
PubMed ID: 20224265Objective: Prostate biopsy for the diagnosis of prostate cancer by transrectal ul...
ABSTRACT Background Urosepsis is a rare but life-threatening complication following transrectal ul...
Introduction: There is still an ongoing debate whether a transrectal ultrasound (TRUS) approach for ...
We present a systematic review providing estimates of the overall and regional burden of infectious ...
Background:The ideal prophylaxis duration for transrectal ultrasonography-guided prostate biopsy is ...
Background: Transrectal ultrasound (TRUS) guided prostate needle biopsy is a commonly used diagnosti...
CONTEXT AND OBJECTIVE: Prostate biopsy is not a procedure without risk. There is concern about major...
Objectives: To determine the risk factors that affect the complication rates of transrectal ultrasou...
Objective: Prostate cancer is a common disease in men proportionally with age. For the diagnosis of ...
Objective: Infection and fever are a major issue of transrectal ultrasound (TRUS)-guided prostate bi...
PURPOSE: The aim of our study was to compare infectious complication rates between different prostat...
Objective: This study was carried out to compare infectious complications between patients with and ...
Background: Prostate biopsy is a standard tool for diagnosing prostate cancer, with more than 4 mill...
AbstractObjectiveInfection and fever are a major issue of transrectal ultrasound (TRUS)-guided prost...
OBJECTIVES: To investigate the complication rate within 30 days after transrectal ultrasound-guided ...
PubMed ID: 20224265Objective: Prostate biopsy for the diagnosis of prostate cancer by transrectal ul...
ABSTRACT Background Urosepsis is a rare but life-threatening complication following transrectal ul...
Introduction: There is still an ongoing debate whether a transrectal ultrasound (TRUS) approach for ...
We present a systematic review providing estimates of the overall and regional burden of infectious ...
Background:The ideal prophylaxis duration for transrectal ultrasonography-guided prostate biopsy is ...